Chemotherapy of Breast Cancer

Michael B. Mosher; Stuart G. Gilbert; A. n.n. Barrett; Richard F. Mould; Laurence Freedman; Gianni Bonadonna; Pinuccia Valagussa; Samuel Hellman; Ben M. Birkhead; Joseph C. Beck; James F. Holland

doi:10.1056/NEJM197606102942413

Chemotherapy of Breast Cancer

Michael B. Mosher
, Stuart G. Gilbert
, A. n.n. Barrett
, Richard F. Mould
, Laurence Freedman
, Gianni Bonadonna
, Pinuccia Valagussa
, Samuel Hellman
, Ben M. Birkhead
, Joseph C. Beck
, James F. Holland

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Abstract

To the Editor: This letter is in reference to Bonadonna's article on adjuvant chemotherapy in breast cancer, which appeared in the February 19 issue. I have followed Dr. Bonadonna's work in the past two years with great excitement. I hoped, and continue to hope, that adjuvant chemotherapy would be the first real dent in the mortality rate of breast cancer. However, in reading the details of his study I was quite disturbed to find that he did not do periodic routine bone scans unless the patient was symptomatic or a lesion became visible on x-ray study. In our practice, of.Â .Â .

Original language	English
Pages (from-to)	1344-1346
Number of pages	3
Journal	New England Journal of Medicine
Volume	294
Issue number	24
DOIs	https://doi.org/10.1056/NEJM197606102942413
State	Published - 10 Jun 1976
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1056/NEJM197606102942413

Cite this

@article{81e999f2f1a24729b6f70079ca9d9908,

title = "Chemotherapy of Breast Cancer",

abstract = "To the Editor: This letter is in reference to Bonadonna's article on adjuvant chemotherapy in breast cancer, which appeared in the February 19 issue. I have followed Dr. Bonadonna's work in the past two years with great excitement. I hoped, and continue to hope, that adjuvant chemotherapy would be the first real dent in the mortality rate of breast cancer. However, in reading the details of his study I was quite disturbed to find that he did not do periodic routine bone scans unless the patient was symptomatic or a lesion became visible on x-ray study. In our practice, of.{\^A} .{\^A} .",

author = "Mosher, \{Michael B.\} and Gilbert, \{Stuart G.\} and Barrett, \{A. n.n.\} and Mould, \{Richard F.\} and Laurence Freedman and Gianni Bonadonna and Pinuccia Valagussa and Samuel Hellman and Birkhead, \{Ben M.\} and Beck, \{Joseph C.\} and Holland, \{James F.\}",

year = "1976",

month = jun,

day = "10",

doi = "10.1056/NEJM197606102942413",

language = "אנגלית",

volume = "294",

pages = "1344--1346",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "24",

}

TY - JOUR

T1 - Chemotherapy of Breast Cancer

AU - Mosher, Michael B.

AU - Gilbert, Stuart G.

AU - Barrett, A. n.n.

AU - Mould, Richard F.

AU - Freedman, Laurence

AU - Bonadonna, Gianni

AU - Valagussa, Pinuccia

AU - Hellman, Samuel

AU - Birkhead, Ben M.

AU - Beck, Joseph C.

AU - Holland, James F.

PY - 1976/6/10

Y1 - 1976/6/10

N2 - To the Editor: This letter is in reference to Bonadonna's article on adjuvant chemotherapy in breast cancer, which appeared in the February 19 issue. I have followed Dr. Bonadonna's work in the past two years with great excitement. I hoped, and continue to hope, that adjuvant chemotherapy would be the first real dent in the mortality rate of breast cancer. However, in reading the details of his study I was quite disturbed to find that he did not do periodic routine bone scans unless the patient was symptomatic or a lesion became visible on x-ray study. In our practice, of.Â .Â .

AB - To the Editor: This letter is in reference to Bonadonna's article on adjuvant chemotherapy in breast cancer, which appeared in the February 19 issue. I have followed Dr. Bonadonna's work in the past two years with great excitement. I hoped, and continue to hope, that adjuvant chemotherapy would be the first real dent in the mortality rate of breast cancer. However, in reading the details of his study I was quite disturbed to find that he did not do periodic routine bone scans unless the patient was symptomatic or a lesion became visible on x-ray study. In our practice, of.Â .Â .

UR - https://www.scopus.com/pages/publications/0017163783

U2 - 10.1056/NEJM197606102942413

DO - 10.1056/NEJM197606102942413

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 1264170

AN - SCOPUS:0017163783

SN - 0028-4793

VL - 294

SP - 1344

EP - 1346

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 24

ER -

Chemotherapy of Breast Cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this